Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
CardiovascularVAGINALGeneric

NYSERT

NYSTATIN

Standard Dose
100,000 UNITS
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NYSERT is listed in Drugs@FDA under application 050478 (NDA).

Marketing status: Discontinued Active ingredient NYSTATIN Form and strength SUPPOSITORY;VAGINAL - 100,000 UNITS Sponsor WARNER CHILCOTT Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview NYSERT is listed in Drugs@FDA under application 050478 (NDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength SUPPOSITORY;VAGINAL - 100,000 UNITS Sponsor WARNER CHILCOTT Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.